DuPont Qualicon

Hygiena will sell DuPont Diagnostics products through its Qualicon Diagnostics unit.

Promega's PowerPlex Fusion System is now approved for use in laboratories that generate DNA records for the National DNA Index System, the company said this week.

DuPont Qualicon said this month that the US Department of Agriculture Food and Safety Inspection Service has approved the DuPont Qualicon BAX STEC assay for screening Shiga toxin-producing strains of Escherichia coli, or STEC.

Seegene and DuPont Nutrition & Health said today that they have inked an agreement to jointly develop highly multiplexed assays to detect foodborne pathogens by combining Seegene's real-time PCR and melt curve analysis technology with DuPont's benchtop BAX System.

Product Watch

Premium

Bio-Rad this week introduced its Precision Melt Supermix for high-resolution-melt-based detection of SNPs and CpG methylation for epigenetic studies.

Biosearch has granted a license to its Black Hole Quencher, CAL Fluor, and Quasar patents to DuPont Qualicon; and will manufacture Scorpions primer oligonucleotides for DuPont for use in food safety diagnostics.

In addition to licensing patents to DuPont, Biosearch will manufacture Scorpions primer oligonucleotides for DuPont's use in food diagnostics.

The company has been adding capabilities to its benchtop PCR-based testing platform through licensing agreements, and is looking to expand use of the system beyond food testing and into pharmaceutical testing and other public health markets.

Idaho Tech recently completed licensing agreements with DuPont Qualicon and two undisclosed life science companies — the latest in a spate of similar deals that take advantage of Idaho Tech's "broad and valuable intellectual property portfolio" in cooperation with Roche Diagnostics.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.